Dashboard/SANOFICONR

SANOFICONR

OVERVALUED

Sanofi Consumer Healthcare India Limited

Healthcare · NSE

↓ 43.0% vs fair value

52W Low

₹3,975

+16.7% from low

52W High

₹5,895

-21.3% from high

News sentiment (0 articles)

0 bull0 neutral0 bear

Valuation Gauge

OVERVALUED-43.0% Margin of Safety

OVERVALUEDFAIRLY VALUEDUNDERVALUED

Current Price

₹4,640

Fair Value

₹3,244

Fair Value Analysis

₹3,244

Based on free cash flow projections and balance sheet strength analysis and earnings growth potential for Healthcare sector companies

High confidence

Cash Flow Analysis

40% weight

₹5,768

Balance Sheet Value

20% weight

₹514

Growth Valuation

40% weight

₹2,085

Price vs Market

SANOFICONR

Nifty 50

Technical Pulse

Plain English — no jargon

RSI 60.7Neutral

52-week range-4.8% from high

L 3,975H 4,811

20-day avg₹4,300▲ 6.5%

📍

Price PositionNeutral

Not enough price history to assess trend.

💪

Momentum (RSI)Overbought

RSI is 61 — overbought territory. Buying has been aggressive, a pullback is possible.

📈

Short-term TrendNeutral

Insufficient data for short-term trend.

→Combined Verdict

Trading significantly above fair value. Unless you believe the business has permanently re-rated, the risk-reward is unfavorable here.

Shareholding Pattern

Stock Health Score

Financially Strong

9.2 / 10

Profitability

10/10

ROE of 73.1% is above the Healthcare sector benchmark of 15% — strong returns

Debt & Leverage

10/10

D/E ratio of 0.1x is well within the Healthcare sector norm of 0.8x — strong balance sheet

Valuation vs Peers

10/10

P/E of 43.6x trades at a 73% discount to Healthcare sector median (160x) — attractively valued

Cash Flow

10/10

FCF margin of 19.0% — exceptional cash generation (₹167 Cr)

Earnings Growth

8/10

5yr EPS CAGR of 20.7% is in line with the Healthcare sector average of 18.7%

Dividend

6/10

Dividend yield of 1.2% provides moderate shareholder returns

Sentiment Trend — Last 30 Days

Historical Returns

Key Ratios & Growth

FCF Yield

4.2%

Free cash flow / market cap

Revenue Growth (YoY)

+46.8%

Year-on-year revenue change

Profit Growth (YoY)

+50.0%

Year-on-year PAT change

Operating Cash Flow

₹439 Cr

TTM cash from operations

Key Financials

EPS (TTM)

₹104.3

P/E Ratio

43.7x

P/B Ratio

40.5x

ROE

73.1%

ROCE

77%

Debt / Equity

0.06x

Beta

—

Div Yield

1.2%

FCF (Cr)

₹167 Cr

Revenue (Cr)

₹878 Cr

EPS Growth 5Y

20.7%

Mkt Cap (Cr)

₹10,559 Cr

52W High

₹5,894.5

52W Low

₹3,975

Book Value/Share

₹112.4

Financial History

Period	Revenue	Op Profit	OPM%	PAT	EPS
TTM	₹878 Cr	₹309 Cr	35.0%	₹240 Cr	₹104.25
2025-03-31	₹878 Cr	₹309 Cr	35.0%	₹240 Cr	₹104.25
2024-12-31	₹724 Cr	₹271 Cr	37.0%	₹181 Cr	₹78.59
2023-12-31	₹555 Cr	₹219 Cr	39.0%	₹165 Cr	—

Compounded Growth Rates

Sales Growth

3Y+16.5%

5Y—

10Y—

Profit Growth

3Y+13.3%

5Y—

10Y—

EPS Growth

3Y—

5Y—

10Y—

Peer Comparison

Healthcare

Stock	Price	Fair Value	MoS%	P/E	ROE	Signal
ALPA Alpa Laboratories Limited	₹62.1	₹198.5	+68.7%	9.4	13.4%	FAIRLY_VALUED
ASTERDM Aster DM Healthcare	₹670	₹1,585.8	+57.8%	103.2	7.9%	UNDERVALUED
UNICHEMLAB Unichem Laboratories Limited	₹300	₹592.5	+49.4%	7.1	12.1%	FAIRLY_VALUED
DCAL Dishman Carbogen Amcis Limited	₹147.6	₹281.2	+47.5%	19.5	1.9%	FAIRLY_VALUED
VIMTALABS Vimta Labs Limited	₹414.8	₹722.6	+42.6%	24.6	16.6%	UNDERVALUED
MOREPENLAB Morepen Laboratories Limited	₹38.4	₹52.8	+27.2%	21	10.8%	FAIRLY_VALUED
INDRAMEDCO Indraprastha Medical Corporation Limited	₹410	₹462.6	+11.4%	20	20.6%	FAIRLY_VALUED
KRONOX Kronox Lab Sciences Limited	₹133	₹130.7	-1.8%	16.9	24.8%	FAIRLY_VALUED

Institutional Activity

Bulk deals, block deals, short selling & delivery volume — NSE data

Insider Trading

Community Pulse

What is Dalal Street saying?

r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket

No Reddit mentions found yet for SANOFICONR.

StockTwits

What traders are saying right now

StockTwits

No StockTwits activity found for SANOFICONR.

Search Interest

Google Trends · India · Last 90 days

Trends

Trend data not yet available — check back soon.

Telegram Channels

ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit

No Telegram mentions found yet for SANOFICONR.

4 articles

Sanofi Consumer Healthcare India Ltd Upgraded to Hold on Technical and Financial Improvements - Markets Mojo

Google News: SANOFICONR·18d ago

Sanofi Consumer Healthcare India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift - Markets Mojo

Google News: SANOFICONR·20d ago

Sanofi Consumer Healthcare India Ltd Faces Bearish Momentum Amid Technical Downgrade - Markets Mojo

Google News: SANOFICONR·21d ago

Sanofi Consumer Healthcare India Ltd Downgraded to Sell Amid Bearish Technicals and Valuation Concerns - Markets Mojo

Google News: SANOFICONR·24d ago

Company Documents

Annual reports, concall transcripts & regulatory filings

📄

Annual Reports

Last 10 years of annual reports via Screener.in

↗🎙️

Concall Transcripts

Quarterly earnings call transcripts & investor presentations

↗🏛️

NSE Filings

Board meeting outcomes, shareholding patterns, corporate actions

↗📊

Balance Sheet & Cash Flow

10-year financial statements on Screener.in

↗

Share this Stock

Download card · Share on WhatsApp

Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant